Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Advanced Hepatocellular Carcinoma
NCT00516165Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in hepatocellular carcinoma (HCC), sponsored by Massachusetts General Hospital. Started Aug 2007; status: completed.
02
Drugs
everolimus
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00516165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516165.